to our mailing list

Abiel is a biotechnology company committed to R&D, production and marketing of innovative high quality lytic enzymes for tissue dissociation in cell therapy and regenerative medicine applications.

Our tissue dissociation enzymes, synthesized by DNA recombinant technology, ensure high stability, batch-to-batch reproducibility and purity.

Abiel's recombinant enzymes represent a step forward towards the optimization and standardization of cell isolation protocols, a major challenge in the future of regenerative medicine and cell therapy.

Abiel also provides services and R&D in the field of lytic enzymes, including the screening, characterization and production of new enzymes from biomarine resources for industry.